Filing Flows

Filing Flows › Companies › RxSight › Timeline

RxSight stock timeline

A year of the price with every insider trade, planned sale, earnings report and material 8-K marked

252 sessions−47.3% to $4.54

RxSight (RXST) stock fell 47% over the last 252 sessions, to $4.54. On the way it reported 4 quarters, its insiders filed 4 open-market trades and 3 Form 144 notices of planned sales, and the company filed 7 material 8-Ks. Each is marked on the price and listed with what the stock did next.

RXST: a year of the stock with every disclosure on itRXST: a year of the stock with every disclosure on it$6.31$8.80$11.29$13.78◆2025-12-19 · Directors and officers: departures, appointments, pay◆2025-12-22 · Directors and officers: departures, appointments, pay◆2025-12-23 · Directors and officers: departures, appointments, pay◆2026-01-12 · Directors and officers: departures, appointments, pay●2026-02-25 · Earnings: beat the EPS estimate by 84.8%◆2026-03-19 · Directors and officers: departures, appointments, pay●2026-05-06 · Earnings: missed the EPS estimate by -28.4%◆2026-07-06 · Material definitive agreement◆2026-07-15 · Directors and officers: departures, appointments, pay●2026-08-05 · Earnings: beat the EPS estimate by 41.4%▽2026-08-18 · Form 144: Raymond W Cohen plans to sell $76K▼2026-09-02 · Goldshleger Ilya sold $14K▼2026-09-02 · Kurtz Ronald M MD sold $35K▼2026-09-02 · Weinberg Eric sold $14K▼2026-09-02 · Wilterding Mark sold $54K▽2026-09-02 · Form 144: Mark Wilterding plans to sell $54K▽2026-09-02 · Form 144: Ronald M MD Kurtz plans to sell $35K●2026-11-03 · Earnings: missed the EPS estimate by -11.5%◆8-K event●Earnings report▽Planned sale (Form 144)▼Insider sale2025-11-062026-11-06
Daily closes, Nov 6, 2025 to Nov 6, 2026; hover a mark for the filing.

Each mark, and what followed

DateKindWhatNext session5 sessions21 sessions
Nov 3, 2026EarningsEarnings: missed the EPS estimate by -11.5%−4.5% (−4.8% vs SPY)——
Sep 2, 2026Form 144Form 144: Ronald M MD Kurtz plans to sell $35K+0.6% (+0.1% vs SPY)−9.9% (−10.0% vs SPY)−38.6% (−39.2% vs SPY)
Sep 2, 2026Form 144Form 144: Mark Wilterding plans to sell $54K+0.6% (+0.1% vs SPY)−9.9% (−10.0% vs SPY)−38.6% (−39.2% vs SPY)
Sep 2, 2026Insider saleWilterding Mark sold $54K+0.6% (+0.1% vs SPY)−9.9% (−10.0% vs SPY)−38.6% (−39.2% vs SPY)
Sep 2, 2026Insider saleWeinberg Eric sold $14K+0.6% (+0.1% vs SPY)−9.9% (−10.0% vs SPY)−38.6% (−39.2% vs SPY)
Sep 2, 2026Insider saleKurtz Ronald M MD sold $35K+0.6% (+0.1% vs SPY)−9.9% (−10.0% vs SPY)−38.6% (−39.2% vs SPY)
Sep 2, 2026Insider saleGoldshleger Ilya sold $14K+0.6% (+0.1% vs SPY)−9.9% (−10.0% vs SPY)−38.6% (−39.2% vs SPY)
Aug 18, 2026Form 144Form 144: Raymond W Cohen plans to sell $76K−1.7% (−1.0% vs SPY)−3.4% (−2.3% vs SPY)−18.2% (−15.8% vs SPY)
Aug 5, 2026EarningsEarnings: beat the EPS estimate by 41.4%+0.6% (+0.8% vs SPY)+11.9% (+12.0% vs SPY)+11.7% (+12.5% vs SPY)
Jul 15, 20268-KDirectors and officers: departures, appointments, pay+5.9% (+6.5% vs SPY)+2.6% (+3.6% vs SPY)+28.9% (+25.9% vs SPY)
Jul 6, 20268-KMaterial definitive agreement+0.4% (+0.8% vs SPY)−10.1% (−9.8% vs SPY)+11.0% (+8.4% vs SPY)
May 6, 2026EarningsEarnings: missed the EPS estimate by -28.4%−6.8% (−8.2% vs SPY)−27.4% (−29.4% vs SPY)−35.3% (−39.8% vs SPY)
Mar 19, 20268-KDirectors and officers: departures, appointments, pay−4.5% (−3.1% vs SPY)−3.8% (−1.8% vs SPY)+9.9% (+2.4% vs SPY)
Feb 25, 2026EarningsEarnings: beat the EPS estimate by 84.8%−1.5% (−2.3% vs SPY)−16.0% (−15.0% vs SPY)−30.5% (−26.2% vs SPY)
Jan 12, 20268-KDirectors and officers: departures, appointments, pay+0.2% (+0.4% vs SPY)−4.4% (−1.8% vs SPY)−22.8% (−22.4% vs SPY)
Dec 23, 20258-KDirectors and officers: departures, appointments, pay+4.0% (+3.7% vs SPY)−5.5% (−4.6% vs SPY)−14.2% (−14.9% vs SPY)
Dec 22, 20258-KDirectors and officers: departures, appointments, pay−10.5% (−11.0% vs SPY)−12.5% (−12.8% vs SPY)−25.1% (−25.8% vs SPY)
Dec 19, 20258-KDirectors and officers: departures, appointments, pay+1.7% (+1.0% vs SPY)−11.2% (−12.3% vs SPY)−19.9% (−21.1% vs SPY)

Insiders’ record here

In the year on the chart, RxSight's insiders reported 0 open-market buys ($0) and 4 sales ($118K).

Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →

What this kind of 8-K usually did

Item8-KsNext session, medianUp next session21 sessions, medianTypical size
5.02 Directors and officers: departures, appointments, pay39,174−0.1%48%+0.7%±1.4%
1.01 Material definitive agreement23,5250.0%51%+1.0%±1.4%

Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →

Report card: every quarter against the estimate → RxSight: every quarter → Live insider trades →

Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.